Structure

InChI Key ZOCKGBMQLCSHFP-KQRAQHLDSA-N
Smiles CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O
InChI
InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C34H36F3NO13
Molecular Weight 723.65
AlogP 2.46
Hydrogen Bond Acceptor 13.0
Hydrogen Bond Donor 5.0
Number of Rotational Bond 10.0
Polar Surface Area 215.22
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 51.0

Bioactivity

Mechanism of Action Action Reference
DNA inhibitor INHIBITOR DailyMed Wikipedia
Protein: DNA topoisomerase II alpha

Description: DNA topoisomerase 2-alpha

Organism : Homo sapiens

P11388 ENSG00000131747
Assay Description Organism Bioactivity Reference
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 4.65 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 15.62 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 6.92 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 6.92 %

Related Entries

Cross References

Resources Reference
ChEBI 135876
ChEMBL CHEMBL1096885
DrugBank DB00385
DrugCentral 2805
FDA SRS 2C6NUM6878
PubChem 454216
SureChEMBL SCHEMBL12824
ZINC ZINC000049783788